Metraipolis › archive › dc_3cc284fc6fdb

Efficacy and Safety of Fexuprazan-Based Modified High-Dose Dual Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial — Europe PMC PMID:42253103

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42253103
DOI
10.1111/hel.70146
License (as archived)
solo-consultazione
Archived
2026-11-02T21:18:41.313Z
SHA-256 of the archived text
92039693747b333c44c27edebf80e85827b8dfb89aff74314f1cd5b3378284fb
Stable URL of this page
https://metraipolis.com/documento/dc_3cc284fc6fdb

How to cite

Efficacy and Safety of Fexuprazan-Based Modified High-Dose Dual Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial — Europe PMC PMID:42253103 — Europe PMC (en), https://europepmc.org/article/MED/42253103 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3cc284fc6fdb (Metraipolis archive dc_3cc284fc6fdb, sha256 92039693747b333c44c27edebf80e85827b8dfb89aff74314f1cd5b3378284fb)
BibTeX
@misc{dc3cc284fc6fdb,
  title = {Efficacy and Safety of Fexuprazan-Based Modified High-Dose Dual Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial — Europe PMC PMID:42253103},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42253103},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3cc284fc6fdb; sha256 92039693747b333c44c27edebf80e85827b8dfb89aff74314f1cd5b3378284fb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42253103. Agents can read the archived copy with the MCP tool read_document.